The biologically active form of D3(1,25-(OH)2D3)binds to the VDR and arrests cells in the G0/G1 phase, thereby inhibiting proliferation and inducing differentiation in various malignancies, such as cell lines of head and neck squamous cell carcinoma (SCCHN) (26). This evidence concerns the gene VDR and head and neck squamous cell carcinoma.